Bicycle Therapeutics (BCYC) Interest Expenses (2021 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Interest Expenses data on file, last reported at $3.6 million in Q2 2026.

• Quarterly Interest Expenses rose 35.5% year-over-year to $3.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.6 million (up 35.5% YoY) and the FY2025 annual result came in at $126.8 million, up 27.18% from the prior year.
• Interest Expenses held at $3.6 million in Q2 2026, from $3.6 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $130.4 million in Q1 2022 to a low of -$1.4 million in Q4 2024.
• A 5-year average of $25.8 million and a median of $11.1 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses soared 24887.55% — and 2024, when it slumped 489.71%.
• Tracing BCYC's Interest Expenses over 5 years: stood at $636000.0 in 2022, then plunged by 138.21% to -$243000.0 in 2023, then tumbled by 489.71% to -$1.4 million in 2024, then soared by 361.76% to $3.8 million in 2025, then slipped by 4.05% to $3.6 million in 2026.
• The last three Interest Expenses figures came in at $3.6 million (Q2 2026), $3.6 million (Q1 2026), and $3.8 million (Q4 2025), per Business Quant data.